Antharas said it expects the IPO to price between $4 and $5 per share. The company applied to list on the Nasdaq Capital Market under the symbol AAS. For the year ended Dec. 31, 2023, the company ...
It would be the first life sciences IPO since BioAge Labs' offering in September. Drug developer Maze Therapeutics Inc.'s rollercoaster ride is leading to the Bay Area's first biotech IPO filing of ...
Titan America, a manufacturer and supplier of heavy building materials and services, plans to sell shares through an initial public offering, according to a Securities and Exchange Commission filing ...